Sarepta Therapeutics buy BiotechBee
Start price
29.10.23
/
50%
€15.09
Target price
31.03.26
€150.00
Performance (%)
-
End price
30.10.23
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sarepta Therapeutics | -2.109% | -2.109% | -85.390% |
| iShares Core DAX® | 0,19 % | -1,22 % | 8,84 % |
| iShares Nasdaq 100 | -1,35 % | -5,31 % | -1,14 % |
| iShares Nikkei 225® | -0,43 % | 7,32 % | 27,58 % |
| iShares S&P 500 | -1,01 % | -3,40 % | -0,22 % |
According to BiotechBee what are the pros and cons of Sarepta Therapeutics for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Sarepta Therapeutics diskutieren
Buy mit Kursziel 150,0
In the thread Trading Sarepta Therapeutics
Buy beendet

